Anthem, Inc. (NYSE:ANTM) Shares Purchased by Montag A & Associates Inc.

Montag A & Associates Inc. boosted its position in Anthem, Inc. (NYSE:ANTMGet Rating) by 43.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 657 shares of the company’s stock after purchasing an additional 200 shares during the quarter. Montag A & Associates Inc.’s holdings in Anthem were worth $305,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in ANTM. Main Street Research LLC purchased a new position in shares of Anthem during the 4th quarter worth about $25,923,000. Capital One Financial Corp acquired a new position in Anthem during the fourth quarter worth approximately $202,000. Horan Securities Inc. purchased a new position in Anthem during the fourth quarter worth approximately $418,000. Orion Portfolio Solutions LLC boosted its holdings in shares of Anthem by 1.7% in the 4th quarter. Orion Portfolio Solutions LLC now owns 4,169 shares of the company’s stock valued at $1,933,000 after purchasing an additional 69 shares during the last quarter. Finally, Evoke Wealth LLC grew its stake in shares of Anthem by 136.6% during the 4th quarter. Evoke Wealth LLC now owns 220 shares of the company’s stock valued at $102,000 after buying an additional 127 shares during the period. 84.28% of the stock is owned by hedge funds and other institutional investors.

Shares of Anthem stock opened at $510.29 on Thursday. The company has a market capitalization of $123.03 billion, a P/E ratio of 20.09, a price-to-earnings-growth ratio of 1.40 and a beta of 0.97. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.36 and a quick ratio of 1.36. The business has a 50-day moving average of $489.29 and a two-hundred day moving average of $455.33. Anthem, Inc. has a 1 year low of $355.43 and a 1 year high of $533.68.

Anthem (NYSE:ANTMGet Rating) last issued its quarterly earnings data on Wednesday, April 20th. The company reported $8.25 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $7.81 by $0.44. Anthem had a return on equity of 18.71% and a net margin of 4.33%. The business had revenue of $38.10 billion during the quarter, compared to analyst estimates of $37.28 billion. During the same period in the previous year, the firm earned $7.01 EPS. Anthem’s quarterly revenue was up 17.6% compared to the same quarter last year. On average, equities analysts anticipate that Anthem, Inc. will post 28.55 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 24th. Investors of record on Friday, June 10th will be issued a dividend of $1.28 per share. This represents a $5.12 dividend on an annualized basis and a dividend yield of 1.00%. This is a positive change from Anthem’s previous quarterly dividend of $1.13. The ex-dividend date of this dividend is Thursday, June 9th. Anthem’s dividend payout ratio (DPR) is presently 20.16%.

In related news, EVP Peter D. Haytaian sold 17,703 shares of Anthem stock in a transaction that occurred on Thursday, March 10th. The stock was sold at an average price of $460.71, for a total value of $8,155,949.13. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CAO Ronald W. Penczek sold 2,763 shares of the business’s stock in a transaction that occurred on Monday, February 7th. The shares were sold at an average price of $453.48, for a total value of $1,252,965.24. The disclosure for this sale can be found here. Insiders sold a total of 22,889 shares of company stock worth $10,532,411 over the last ninety days. 0.28% of the stock is currently owned by insiders.

Several research analysts recently weighed in on ANTM shares. The Goldman Sachs Group increased their target price on Anthem from $527.00 to $605.00 and gave the stock a “buy” rating in a research report on Thursday, April 21st. BMO Capital Markets lifted their price objective on Anthem from $540.00 to $625.00 and gave the company an “outperform” rating in a research note on Monday, April 25th. Cowen lifted their target price on shares of Anthem from $472.00 to $642.00 in a report on Thursday, April 21st. Mizuho upped their target price on Anthem from $510.00 to $545.00 in a research report on Wednesday. Finally, Credit Suisse Group increased their target price on Anthem from $518.00 to $584.00 and gave the company an “outperform” rating in a research note on Thursday, April 21st. Two analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $545.23.

Anthem Profile (Get Rating)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.

Read More

Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTMGet Rating).

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.